Elizabeth Ogando-Rivas1, Andrew F Alalade1, Jerome Boatey1, Theodore H Schwartz2,3,4. 1. Department of Neurosurgery, New York Presbyterian Hospital, Weill Cornell Medical College, Box 99, 525 East 68th St., New York, NY, 10065, USA. 2. Department of Neurosurgery, New York Presbyterian Hospital, Weill Cornell Medical College, Box 99, 525 East 68th St., New York, NY, 10065, USA. schwarh@med.cornell.edu. 3. Department of Otolaryngology, New York Presbyterian Hospital, Weill Cornell Medical College, Box 99, 525 East 68th St., New York, NY, 10065, USA. schwarh@med.cornell.edu. 4. Department of Neuroscience, New York Presbyterian Hospital, Weill Cornell Medical College, Box 99, 525 East 68th St., New York, NY, 10065, USA. schwarh@med.cornell.edu.
Abstract
INTRODUCTION: Double adenomas in the pituitary gland are a rare occurrence. The ability to cure a hormone-producing adenoma with surgery is dependent on the ability to identify and completely remove the correct adenoma. The relative frequency of each subtype of hormone-secreting adenomas confirmed with magnetic resonance image (MRI), surgery and immunohistochemistry is not defined. METHODS: Following PRISMA guidelines, we performed a systematic review of PubMed Central, Google Scholar, Scopus Database, Cochrane database and Science Research, using the key-words: "double pituitary adenomas", "multiple pituitary adenomas" and only papers where multiple or truly separate double pituitary adenomas were identified pre-surgically by MRI and/or confirmed by pathology/immunohistochemistry staining were included. RESULTS: We reviewed papers from 1975 to 2016 and found 17 cases with two pituitary adenomas and 1 with three pituitary adenomas. The ages ranged from 22 to 67 years old, and there were twelve females and five males. Immunohistochemical staining showed that the most common double pituitary adenomas were growth hormone (GH)- followed by adrenocorticotropic (ACTH)-secreting. CONCLUSION: Double pituitary adenomas are rare but most commonly found with GH- or ACTH-producing tumors. It is critical to remove all identified possible adenomas to achieve biochemical cure and clinicians should have heightened sensitivity in patients with acromegaly or Cushing's Disease.
INTRODUCTION: Double adenomas in the pituitary gland are a rare occurrence. The ability to cure a hormone-producing adenoma with surgery is dependent on the ability to identify and completely remove the correct adenoma. The relative frequency of each subtype of hormone-secreting adenomas confirmed with magnetic resonance image (MRI), surgery and immunohistochemistry is not defined. METHODS: Following PRISMA guidelines, we performed a systematic review of PubMed Central, Google Scholar, Scopus Database, Cochrane database and Science Research, using the key-words: "double pituitary adenomas", "multiple pituitary adenomas" and only papers where multiple or truly separate double pituitary adenomas were identified pre-surgically by MRI and/or confirmed by pathology/immunohistochemistry staining were included. RESULTS: We reviewed papers from 1975 to 2016 and found 17 cases with two pituitary adenomas and 1 with three pituitary adenomas. The ages ranged from 22 to 67 years old, and there were twelve females and five males. Immunohistochemical staining showed that the most common double pituitary adenomas were growth hormone (GH)- followed by adrenocorticotropic (ACTH)-secreting. CONCLUSION: Double pituitary adenomas are rare but most commonly found with GH- or ACTH-producing tumors. It is critical to remove all identified possible adenomas to achieve biochemical cure and clinicians should have heightened sensitivity in patients with acromegaly or Cushing's Disease.
Authors: Ricardo J Komotar; Robert M Starke; Daniel M S Raper; Vijay K Anand; Theodore H Schwartz Journal: Pituitary Date: 2012-06 Impact factor: 4.107
Authors: F Magri; C Villa; D Locatelli; P Scagnelli; M S Lagonigro; P Morbini; M Castellano; E Gabellieri; M Rotondi; E Solcia; A F Daly; L Chiovato Journal: J Endocrinol Invest Date: 2009-12-01 Impact factor: 4.256
Authors: Jannik von Schöning; Jörg Flitsch; Dieter K Lüdecke; Rudolf Fahlbusch; Michael Buchfelder; Rolf Buslei; Ulrich J Knappe; Markus Bergmann; Walter J Schulz-Schaeffer; Jochen Herms; Markus Glatzel; Wolfgang Saeger Journal: Hormones (Athens) Date: 2022-08-10 Impact factor: 3.419
Authors: Grzegorz Zieliński; Emir Ahmed Sajjad; Maria Maksymowicz; Monika Pękul; Andrzej Koziarski Journal: Pituitary Date: 2019-12 Impact factor: 4.107
Authors: Melanie Schorr; Xun Zhang; Wenxiu Zhao; Parisa Abedi; Kate E Lines; E Tessa Hedley-Whyte; Brooke Swearingen; Anne Klibanski; Karen K Miller; Rajesh V Thakker; Lisa B Nachtigall Journal: AACE Clin Case Rep Date: 2019-06-07